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Abstract Low plasma levels of high-density lipoprotein
cholesterol (HDL-C) are identified as a risk factor for
cardiovascular disease (CVD). Sexual dimorphism, how-
ever, is widely reported in both HDL-C and CVD, with the
underlying explanations of these sexual differences not
fully understood. HDL-C is a complex trait influenced by
both genes and dietary factors. Here we examine evidence
for a sex-specific effect of APOE and the macronutrient
carbohydrate on HDL-C, triglycerides (TG) and apoprotein
A-1 (ApoA-1) in a sample of 326 male and 423 female
participants of the Strong Heart Family Study (SHFS).
Using general estimating equations in SAS to account for
kinship correlations, stratifying by sex, and adjusting for
age, body mass index (BMI) and SHS center, we examine
the relationship between APOE genotype and carbohydrate
intake on circulating levels of HDL-C, TG, and ApoA-1
through a series of carbohydrate-by-sex interactions and
stratified analyses. APOE-by-carbohydrate intake shows
significant sex-specific effects. All males had similar
decreases in HDL-C levels associated with increased car-
bohydrate intake. However, only those females with
APOE-4 alleles showed significantly lower HDL-C levels
as their percent of carbohydrate intake increased, while no
association was noted between carbohydrate intake and
HDL-C in those females without an APOE-4 allele. These
findings demonstrate the importance of understanding sex
differences in gene-by-nutrient interaction when examining
the complex architecture of HDL-C variation.
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Introduction
Dietary manipulation of plasma cholesterol levels is widely
accepted as a primary step in the treatment of dyslipidemias
and prevention of their sequelae of atherosclerosis and
cardiovascular disease (CVD). Past dietary recommenda-
tions to lower plasma cholesterol emphasized a low-fat diet
with a higher intake of complex carbohydrate, yet studies
vary in the extent to which either macronutrient influences
lipoprotein risk factors [25, 27, 45, 62]. The low-fat diet has
not proven universally effective in lowering risk profiles
[77], suggesting an underlying genetic variation in dietary
response [56]. Moreover, diets high in carbohydrate intake
are frequently shown to decrease plasma levels of high-
density lipoprotein (HDL) cholesterol (HDL-C) [14, 42] and
increase circulating triglycerides (TG) [59]. Such an inverse
correlation between plasma triglycerides and HDL-C is
widely reported across populations, despite dietary differ-
ences [53]. High-density lipoprotein (HDL) is the major
lipoprotein of the reverse cholesterol transport system
thought to be protective against atherosclerosis. HDL-C is
viewed as an indicator of the efficacy of this reverse trans-
port system [12]. The inverse relationship of carbohydrate
intake to HDL-C was introduced over 20 years ago [68],
with studies indicating that this relationship began in early
childhood [72]. Growing evidence supports the presence of
the cardio-protective role of higher plasma HDL [3, 49].
Long-term studies now suggest that low-fat, high carbohy-
drate diets may have exacerbated current problems of
obesity, type II diabetes, and the metabolic syndrome [77].
These factors show an association with lower HDL in both
males and females [20, 74, 78]. Variation in carbohydrate
effects on lipid risk factors may indeed be influenced by the
quality of the carbohydrate [59] or other population-specific
factors [46, 69]. Although the current dietary recommen-
dations now focus on quality rather than the quantity of
carbohydrate, protein and fat intake [1, 4, 41], the results
from studies of dietary relationship to plasma lipids remain
inconsistent. The issue of sex-specific variation as a factor in
the response of plasma lipids to variation in dietary ma-
cronutrients appears consistently in many studies, however
[16, 40, 58]. We hypothesize that a genetic predisposition
and sexual dimorphism may explain some of the variation in
response of HDL-C levels to dietary carbohydrate intake
[47, 51].
Apoproteins are the major protein moiety of plasma
lipoproteins and responsible for a variety of roles including
stimulation of the synthesis of lipoproteins, cofactors for
lipoprotein modulating enzymes, and ligands for lipoprotein
receptors. Our candidate gene, apoprotein E (APOE) has a
major polymorphism with three major alleles (e2, e3, and
e4). The accepted wild type is e3 ([60% in all populations
studied), with e2 and e4 distinguished by a one base-pair
substitution at different locations; e4(Cys112 to Arg) and e2
(Arg158 to Cys) [10, 21, 76]. The three resulting isoforms
have well-documented variation in functional effects [43,
70]. APOE is a ligand for several cell membrane receptors
of the triglyceride-laden low-density lipoproteins chylomi-
crons and VLDL. APOE also assists in cholesterol efflux
from macrophages and mediates uptake of the reverse
transport lipoprotein, HDL [11, 49]. Using the binding
capacity of E3 as the referent, studies indicates that E2 has
an impaired binding, while studies of E4 report somewhat
inconsistent results, with E4 binding either similarly to E3
[10] or at an enhanced capacity [2]. Research further sug-
gests preferential binding of E4 to large triglyceride-rich
very-low-density lipoproteins (VLDL), while E2 and E3
show preference to the HDL [9].
The plasma lipoprotein response of APOE genotype to
dietary fat and cholesterol has been extensively examined,
while the response to variation in carbohydrate intake has
been virtually ignored until recently [57, 58]. Sex-specific
associations are documented between APOE variants and
plasma lipoproteins [17, 57, 65] and between APOE variants
and the risk of CVD [35]. Current research demonstrates the
benefits of examining APOE within the context of a sex-
stratified approach in order to develop a clear picture of gene
action on each of the plasma lipoproteins [73]. Here we
examine the sex-specific relationship of APOE alleles and
the dietary percent of carbohydrate intake on plasma levels
of HDL-C, TG, and apoprotein A-1 (ApoA-1), a primary
component in regulating the biosynthesis of HDL [60].
Methods
Sample
The Strong Heart Study (SHS) is a longitudinal study to
determine CVD risk factors among 13 American Indian
tribes in three geographical areas across the central plains
and the southwest. The Institutional Review Board (IRB) of
the Indian Health Service, and the collaborating education
institutions approved the study protocol. Initiated in 1989,
this study completed baseline exams between 1989 and
1992. The exams consisted of personal interviews, anthro-
pometrics, and physical exams including laboratory tests.
Original participants, aged 45–74, included individuals
diagnosed for diabetes [28]. The Strong Heart Family Study
(SHFS), a component of the SHS, is a family study that has
recruited and examined more than 3,800 individuals in
multiple extended families. Between 1997 and 1999, a subset
of family study participants, including 320 males and 421
females ages 18–88, completed prompted 24-h dietary
recalls and gave fasting blood samples for lipid profiles and
genotyping [55]. This subset is the sample used for this study.
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Phenotyping
Phenotyping for plasma lipoproteins, apoproteins, triglyc-
erides, insulin and glucose was completed from blood
samples drawn after a 12 hour fast. Assays were performed
at the MedStar Research Institute, following standard lab-
oratory procedures described elsewhere (http://strongheart.
ouhsc.edu/manual/PhaseV/Vol01.pdf) [37]. HDL-C, tri-
glycerides (TG), apoprotein A-1, were determined using
enzymatic reagents and the Hitachi 717 (Boehringer
Mannheim Diagnostics), while LDL-C was determined
using the Friedewald equation for individuals with TG \
400 mg/dl. For those participants with TG [ 400 mg/dl,
the LDL was directly assessed [15, 54]. Fasting insulin was
determined through a modified method of the polyethylene
glycol-double antibody radioimmunoassay [36], and glu-
cose levels were assayed through the hexokinase method
(Glucose-HK: Beohringer Mannheim Diagnostics, India-
napolis, IN), also on the Hitachi 717 [54]. APOE
phenotypes were determined using 2 h of isoelectric
focusing followed by immunoblotting to identify APOE
bands [31, 33] and used to infer genotypes [48].
Body mass index (BMI) was calculated by Quetelet’s
index: weight (kg)/height (m)2 [38]. These measures of
weight and height were both sampled with participants
wearing light clothing and no shoes [28]. The percent of
body fat was determined through an impedance meter and
equations based upon total body water [26]. Dietary pro-
files were collected using an interview-prompted 24 hour
recall. Nutrient data were determined from these dietary
recalls using nutrient data system [67]. Macronutrient
intake was assessed as the percent of total caloric intake
and includes the percent of fat (9 kcal/gm), protein and
carbohydrate (both 4 kcal/gm). Carbohydrates were not
differentiated into complex and simple carbohydrate, and
are therefore not categorized for glycemic index [30, 72].
Diabetes status was defined by three categories: those
without diabetes, those diagnosed with diabetes and those
with impaired glucose tolerance, ascertained by fasting
glucose and insulin levels. The categories were in accor-
dance with the World Health Organization criteria of 1980
and detailed in a strong heart study publication by Kataoka
et al. [32].
Statistical analyses
Data were initially examined with multivariate analyses in
SPSS 11.5, analyzing both unadjusted lipoprotein measures
(HDL and TG log-transformed) and standardized residuals
of lipids after adjustment by the basic model. Dietary
intake was categorized into sex-stratified tertiles of mac-
ronutrient intake. Results were then verified within the SAS
software system (SAS Institute, version 8.0, Cary, NC) in
order to implement general estimating equations (GEE).
These GEE models and mixed model analysis of variance
(ANOVA) allow tests of association while accounting for
the correlation among members within common pedigrees.
We are reporting results obtained using GEE models in this
paper.
APOE allele frequencies were estimated by gene
counting, and the familial-based data were evaluated for
Mendelian inconsistencies and cleaned of pedigree errors
using PREST and the effects of genotyping error using
Simwalk II, both described in detail elsewhere, [54, 71, 75]
and (http://strongheart.ouhsc.edu/manual/PhaseV/). Indi-
viduals were grouped into two categories, those without an
e4 allele and those with an e4 allele. As the frequency of
individuals with at least one e2 allele was minimal and
similar for both males and females, they were consolidated
within the corresponding study categories, with or without
e4. Therefore, genotype e3/2 was included with e3/3, and
e4/2 included with may e3/4 and e4/4. No homozygote e2/
2 was noted in the sample.
We assessed the association between carbohydrate
intake, genotype, and their interaction on HDL-C, TG and
APOA-l, using mixed model analysis of variance for
continuous, normally distributed traits and generalized
estimating equations (GEE) for categorical traits. The
GEE method estimates within-pedigree similarity of
residuals to reestimate regression parameters and thus
calculate more accurate standard errors [22]. We specified
an exchangeable correlation structure for these analyses,
which should have been slightly conservative. Analyses
were completed on the sex-stratified analyses and tests
of genotype-by-sex interaction, diet-by-sex, genotype-by-
diet, and genotype-by-diet-by-sex interaction were per-
formed. We used two levels of covariate adjustment: (a)
base model: SHS center, age, BMI; and (b) a fully
adjusted model that includes the base model adjustment
factors, with the additional factors of body fat, fasting
insulin, glucose levels and diabetes status. Continuous
outcomes were first examined for adherence to distribu-
tional assumptions (including approximate normality of
error terms conditional on covariates and homoscedastic-
ity) and appropriate transformations were made when
necessary. Specifically, HDL-C and TG were natural log-




Table 1 present the descriptions of this Strong Heart
Family Study sample as a whole, with adiposity and
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diabetes related traits, lipid profiles, and dietary data for
both males and females. Participants’ ages ranged from 18–
89 years, with a mean of 39 years for both males and
females. A total of 54% of the males and 62% of the
females had BMI scores C30 (data not shown), indicating a
substantial proportion of obese individuals in this sample
[34]. As expected, the percent of body fat was higher in
females than males. Sexual dimorphism was also present in
the plasma lipids, with females exhibiting significantly
higher circulating levels of HDL-C and APOA-1 and lower
levels of TG, LDL-C and total cholesterol (TC). Dietary
differences between males and females were statistically
significant only for total caloric intake and carbohydrate
percent of total intake, with females taking in fewer
calories but a higher percent in carbohydrate than males.
The percent of individuals experiencing diabetes or
impaired glucose tolerance was 30.6 for males, 31.6 for
females (Table 1).
APOE allele and genotype frequencies are shown in
Table 2. Further delineation of characteristics between
APOE study categories identified distinct genotypic dif-
ferences (Table 3), using least squared means to account
for the covariates within the data. Males carrying the e4
allele had significantly increased BMI and body fat, with-
out a significant difference in total calorie intake or nutrient
intake. Levels of fasting insulin were higher in males with
e4. In contrast, no significant differences were noted in
females for adiposity-related characteristics or diabetes-
related traits. Both males and females carrying an e4 allele
exhibited lower HDL-C and APOA-1 levels, however, the
effects of genotype were more pronounced in AHA HDL
risk categories in females than males.
Main effect of diet
In the initial analyses with SPSS, only carbohydrate intake
remained consistently associated with any lipid measure,
and specifically only with HDL-C (data not shown). We
changed to SAS with GEE to accommodate any effect for
pedigrees and identified the main effect of carbohydrate
intake on HDL-C and TG variation to be statistically sig-
nificant in males only (see Table 4). Findings were
consistent for carbohydrate intake regardless of covariate
adjustment, in both the base model and the fully adjusted
model (additionally adjusted for body fat, diabetes status,
fasting insulin and glucose levels). Carbohydrate intake
was not associated with APOA-1 variation in either males
or females.
Table 1 Characteristics of Strong Heart Family participants
Trait Mean (SE) Mean (SE) P valuee
Age (years) 39.5 (1.3) 40.1 (1.2) 0.60
BMIa 32.9 (1.0) 34.1 (0.9) 0.027
BFb (%) 31.2 (1.1) 43.3 (1.1) \0.001
FG (mg/dl) 123.2 (5.2) 125.8 (5.0) 0.72
FI (mIU/l) 26.9 (3.3) 28.4 (3.2) 0.075
Diabetes status
Diabetic (%) 20.7 24.9 0.052
IGT (%) 9.9 6.7 0.073
Lipids
TC (mg/dl) 180.9 (3.4) 174.0 (3.3) 0.008
HDL (mg/dl) 42.0 (1.5) 45.2 (1.5) \0.001
HDL/AHAc
\40 (%) 54.8 44.6 0.075
41–59 (%) 36.6 43.6 0.095
[60 (%) 8.6 11.8 0.26
LDL (mg/dl) 117.1 (2.4) 109.1 (2.2) \0.001
TG (mg/dl) 136.6 (5.3) 123.0 (4.9) 0.029
APOA-1 (mg/dl) 1.3 (0.03) 1.37 (0.03) \0.001
Dietaryd
Total (Kcal) 2,303.6 (58.7) 1,899.1(52.5) \0.001
Carb (%) 50.3 (0.9) 52.8 (0.8) 0.005
Prot (%) 14.4 (0.3) 13.9 (0.3) 0.65
Fat (%) 34.2 (0.7) 33.9 (0.7) 0.24
a BMI = kg/m2
b BF = body fat (% of body composition)
c HDL-AHA = risk categories % of population
d Dietary traits = percent of total daily caloric intake
e P values were determined using generalized linear mixed models
(continuous outcomes) and generalized estimating equations (cate-
gorical outcomes), which controlled for the correlation among
members in the same pedigrees
FG = fasting glucose, FI = fasting insulin—% of sample, Diabetes
status = diabetes and IGT (impaired glucose tolerance) % of
population
Table 2 Frequency of APOE alleles and genotypes in both males and
females
Males (n = 321) Females (n = 423)
n Frequency n Frequency
APOE alleles
e2 13 0.02 15 0.02
e3 539 0.84 732 0.87
e4 90 0.14 101 0.12
Genotypes
2/2 0 0.000 0 0.000
2/3 11 0.003 13 0.003
3/3 225 0.701 315 0.745
3/4 78 0.243 89 0.210
4/2 2 0.006 1 0.002
4/4 5 0.002 5 0.001
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Main effect of genotype
Genotypic differences were noted in HDL-C and APOA-1
levels, with significantly lower levels in both males and
females carrying the e4 allele (Table 3). After the adjust-
ment for covariates, only APOA-1 remained significantly
different for both males and females, while the main effect
of APOE remained statistically significant for HDL-C in
females only. No effect of APOE genotype was significant
for TG levels (Table 4).
Interaction between diet and genotype
Because sex-specific effects of diet and genotype were
observed, we assessed the evidence for diet-by-genotype
interaction in males and females separately. Interaction
between carbohydrate intake and APOE genotype in vari-
ation in HDL-C levels was observed in females only, in
both the base and fully adjusted models (Table 4). Plasma
HDL-C levels of females without an e4 allele showed no
association with carbohydrate intake, whereas females
Table 3 Characteristics of individuals stratified by APOE genotypes
Males Pe Females Pe
Without e4 (n=236) With e4 (n=85) Without e4 (n=329) With e4 (n=94)
Trait LS-Mean (SE) LS-Mean (SE) LS-Mean (SE) LS-Mean (SE)
Age (year) 39.3 (0.9) 36.5 (1.6) 0.12 40.6 (1.3) 39.5 (1.8) 0.51
BMIa 32.3 (0.9) 34.6 (1.2) 0.009 33.8 (1.2) 35.6 (1.4) 0.12
BFb (%) 30.9 (1.1) 33.3 (1.3) 0.012 42.9 (1.2) 44.1 (1.4) 0.18
FG (mg/dl) 115.9 (4.1) 122.8 (6.3) 0.24 130.0 (7.2) 126.9 (8.8) 0.79
FI (mIU/l) 28.8 (4.2) 33.4 (5.1) 0.042 24.8 (1.4) 26.3 (2.7) 0.25
Diabetes status
Diabetic (%) 18.6 26.0 0.17 25.2 23.4 0.63
IGTc (%) 10.6 7.0 0.33 6.4 6.4 0.99
Lipids
TC (mg/dl) 180.0 (3.6) 178.8 (4.9) 0.74 176.0 (3.7) 175.6 (4.8) 0.92
HDL (mg/dl) 43.7 (1.7) 39.5 (2.1) 0.029 45.3 (1.6) 41.6 (1.9) 0.012
HDL-AHA
\40 (%) 51.7 61.2 0.13 41.6 53.4 0.004
41–59 (%) 37.3 35.2 0.56 44.4 40.4 0.15
[60 (%) 10.6 3.5 0.11 13.4 6.4 0.024
LDL (mg/dl) 115.4 (3.0) 118.6 (4.1) 0.44 109.9 (2.2) 113.2 (3.2) 0.29
TG (mg/dl) 130.2 (7.3) 141.8 (10.1) 0.10 126.8 (5.0) 121.4 (7.7) 0.62
APOA-1 (mg/dl) 1.33 (0.03) 1.21 (0.03) \0.001 1.38 (0.04) 1.29 (0.04) 0.004
Dietaryd
Total (Kcal) 2,373 (85) 2,112 (128) 0.075 1,914 (50) 1,816 (91) 0.65
Carb (%) 50.2 (1.0) 50.4 (1.5) 0.88 52.2 (0.8) 53.2 (1.3) 0.45
Prot (%) 14.3 (0.4) 15.0 (0.6) 0.46 14.0 (0.3) 13.8 (0.5) 0.67
Fat (%) 34.3 (0.9) 32.9 (1.3) 0.28 34.4 (0.6) 33.8 (1.0) 0.57
Genotypes pooled into two groups: those without e4 and those with e4 allele. P values indicate significant differences between genotypes, within
sex
a BMI = kg/m2
b BF = body fat
c IGT = impaired glucose tolerance
d Dietary traits = percent of total daily Kcal intake
e Significant P B 0.05 in generalized linear mixed models (continuous outcomes) or generalized estimating equations (categorical outcomes),
which controlled for the correlation among members in the same pedigrees
FG = fasting glucose, FI = fasting insulin
Genes Nutr (2008) 3:87–97 91
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carrying an e4 allele demonstrated a highly significant
association. In contrast, an inverse relationship between
HDL-C and carbohydrate intake was noted in males, but no
effect modification by APOE genotype was observed
(Fig. 1). No effect of interaction was noted in either sex for
TG or APOA-1 levels, regardless of covariate adjustment.
Discussion
Sexual dimorphism of HDL-C levels and CVD is widely
reported in many populations, yet underlying mechanisms
for these differences are not fully understood. Controlling
for age, SHS center and BMI, fasting blood sugar and
insulin levels, and diabetic status, we identified an inter-
action between sex, APOE genotype, and carbohydrate
intake on plasma HDL-C levels. This gene-by-macronu-
trient interaction was restricted to the female SHFS
participants. As dietary manipulation of plasma lipids is the
initial strategy in CVD prevention, identifying factors
which affect circulating HDL-C may support the ability to
implement more effective individually-tailored dietary
intervention.
HDL remains an important risk modifier in cardiovas-
cular diseases. Beyond its putative role of sequestering and
transporting cholesterol and other detrimental products back
to the liver for disposal, HDL is believed to inhibit endo-
thelial inflammation and promote production of endothelial
nitric oxide (NO) and prostacyclins [39]. Variation in HDL
levels is believed to be primarily associated with variation in
clearance, except in dietary studies which have identified
that fat intake affects HDL production or transport rates
[61]. Although we cannot identify the specific metabolic
effects on HDL-C variation here, as plasma levels of
APOA-1 are not associated with carbohydrate intake, our
findings suggest that catabolism may be the more likely
mechanism affecting HDL-C variation in this study.
Moreover, with carbohydrate intake not the traditionally
studied macronutrient for association with APOE, our
findings demonstrate the importance of including carbohy-
drate intake in a sex-specific context, when examining the
genetic and dietary influence underlying HDL-C variation.
Genotype effects
APOE polymorphisms and their distinct isoforms are the
most widely studied of the apoproteins. The Strong Heart
Study population exhibits a higher frequency of the wild
type e3 and lower frequencies of e2 and e4 than seen in
many populations worldwide [32, 50], yet a profile similar
to other American and Mexican Indian populations [8, 19].
Acting as the major ligand for clearance of triglyceride-rich
lipoproteins and HDL through cellular receptors, APOE
function may vary depending upon the lipoprotein with
which it is connected and include additional anti-athero-
genic properties [60, 63]. Dallongeville et al. meta-analyses
of studies from 17 countries evaluated the relationship of
Table 4 P values for tests of main effects and interaction of sex,
APOE and carbohydrate, with table representing results of maximum
model (basic adjustment and adjustment for measures of diabetes,















Males 0.14 0.029 0.17
Females 0.0003 0.11 0.0006
Log(ApoA1)
Sex-combined 0.060
Males 0.084 0.14 \0.0001
Females 0.063 0.56 0.0023
Log(trigs)
Sex-combined 0.58
Males 0.47 0.018 0.54
Females 0.92 0.53 0.60
Adjustments made for basic model, then incremental additions with
measures of diabetes, body fat, and fasting insulin and glucose levels.
Interaction models adjusted for all lower order terms. Basic model
adjusted for age, SHS center, BMI; Maximum model adjustment for 2
diabetes variables (s3adadm and s3adaifg), body fat (s3fat), glucose
(s3g0) and fasting insulin (s3insu). Models with interactions are
adjusted for all lower order terms
a Performed on sex-combined sample
b Performed on sex-stratified samples
c Performed on sex-stratified samples only if P value for carb 9
APOE interaction was not significant in the previous model




















Fig. 1 Log(HDL) versus carbohydrates by gender and ApoE
genotype
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APOE with plasma cholesterol. Reporting consistent find-
ings in the relationships, the authors suggested variation in
amplitude of effect between populations. No clear associ-
ation was noted between HDL-C and those APOE
phenotypes carrying one allele of e2, however, HDL-C
variation between individuals with e3/3, e3/4, and e4/4 was
reported. Additionally, aside from the expected association
of e2 with elevated TG, these authors also reported a sig-
nificant association of higher TG and lower HDL-C with
the heterozygote e3/4 genotypes than in lipid levels of
homozygotes e3/3 and e4/4. Moreover, they stressed that
these relationships remained consistent in a variety of
populations including children, diabetics, obese, and
hyperlipidemic individuals [7]. However, while this study
did include both males and females, it did not address sex-
specific variation. Hallman’s nine country study reported
consistent associations of APOE genotype with total cho-
lesterol levels among the countries, despite assumed
dietary differences. No direct measure of any dietary
variable was included in that study, nor were the data
sex-stratified [21].
Kataoka et al. [32] study examining the relationship of
APOE polymorphisms to plasma lipids in the original
Strong Heart Study individuals (n = 4,410), reported sex-
specific variation associated with APOE polymorphisms.
Genotype was not significantly associated with HDL-C
variation in males (ages 45–64), however, in females, a
significant trend for HDL-C levels was noted in all female
subgroups studied: normal and diabetic, premenopausal
and menopausal. HDL-C was higher in females carrying an
e2 and lower in individuals carrying an e4 than for females
with e3/3 genotypes. Genotype variation was noted for TG
differences in males only, with e2 and e4 having higher TG
levels than males homozygous for e3/3 genotype in both
normal and diabetic individuals. Dietary factors were not
considered in the study [32].
Many other studies document sex-specific effects of
APOE on plasma lipids in a variety of populations, although
various lipid effects are not consistent throughout the
studies [13, 18, 44, 50, 52, 64, 66]. The complexity of the
interrelatedness of the lipid system with its constant
remodeling of lipoproteins, makes study comparisons dif-
ficult. The relationship of APOE to lipids has been shown to
be age and context dependent, with increased heterogeneity
of variance in older participants attributable to cumulative
environmental effects reflecting greater variation in diet,
exercise and other factors. Unique environmental variation
is offered as an explanation for some inconsistencies [52]. A
recent review article proposed that gender and hypergly-
cemia were two of the primary environmental factors
affecting the APOE-HDL-C relationship [18], which points
to variation in carbohydrate intake and metabolism as
moderating factors in HDL-C variation.
Dietary effects
The varied relationships between carbohydrate intake and
plasma HDL-C have long been acknowledged in the lit-
erature [42, 68]. The recent focus on macronutrient quality
emphasizing complex carbohydrates, to include both sol-
uble and insoluble dietary fibers, has sparked renewed
interest in physiological responses to carbohydrate intake.
Traditional dietary studies examining nutrient association
with lipid profiles concentrated on fatty acids and choles-
terol intake, and most studies examined males only [58].
Few studies have quantified sex-specific variation directly,
choosing instead to adjust for any sex differences and
suggest that the discrepancies between studies may be
based on unidentified sex variation in dietary response [5].
This approach of adjusting for sex differences has been
challenged for genetic studies by Stengard et al. [73] who
suggest that pooling sex data results in findings which do
not adequately reflect the genotype effects on phenotypic
variation in either sex.
Differences between sexes were reported in the National
Health and Nutrition Examination Study (NHANES III,
1988–1994), with higher carbohydrate intake associated
with lower HDL in males and elevated TG in females, BMI
in both males and females, and glucose levels in males only
[80]. In our study, the main effect of carbohydrate intake
was significantly associated with lower HDL-C and higher
TG in males only, after adjustment for BMI and traits
associated with glucose levels.
Interaction of APOE and carbohydrate
Polymorphisms of APOE have been shown to affect vari-
ation in plasma lipid profiles when associated with dietary
nutrients. Traditionally, studies have examined cholesterol
and fat intake and indicated that individuals with an e4
allele have greater plasma lipid sensitivity in LDL and TG
to dietary variation [18]. Most reported studies of diet-
APOE interaction are documented in males only [58]. Our
study compared males and females of similar backgrounds
and families to identify a sex-specific APOE genotype
vulnerability to carbohydrate effects on HDL-C levels in
females only, a vulnerability which remained consistent
after adjusting for center, age, adiposity and glucose
altering traits. We used additional analyses on these data,
defining carbohydrate intake in sex-stratified tertiles and
applying a general linear model in SPSS 11.5 to substan-
tiate these findings (results not shown).
Several studies have shown little variation in lipid pat-
terns between hyperglycemic and diabetic groups when
comparing APOE genotypes across quintiles of glucose
levels. One, however, reported APOE-serum glucose
interaction affecting variation in HDL-C and APOA-1 in
Genes Nutr (2008) 3:87–97 93
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both males and females, and TG in males only [18].
Adjusting for the basic model and each glucose altering
trait separately did not alter our outcome (Table 4), and
APOA-1 variation was not affected by carbohydrate intake
in either males or females in any of our models.
The association pattern of HDL-C with APOE poly-
morphisms in our study reflected Kataoka et al’s findings in
females, and only when carbohydrate was a factor. We
believe that these findings reinforce the importance of
further examining the relationship of carbohydrate intake
to HDL variation. Most importantly, these findings support
our hypothesis that genetic predisposition and sexual
dimorphism are in fact present in the response of HDL-C to
carbohydrate intake (Fig. 1).
Two issues must be noted here: (a) the between sex
variation noted in individuals carrying the common e3, and
(b) within sex HDL-C variation of APOE genotypes seen
in females. The first might be explained through sexual
dimorphism noted in lipid metabolism, with females
showing a greater sensitivity to insulin’s antilipolytic
effects, and suppression of postprandial plasma fatty acid
concentrations to compensate for their higher basal fatty
acid flux [47]. The second issue may be connected to e4 as
an effective ligand for triglyceride-rich lipoproteins (TRL),
and high levels of APOE in HDL-C appearing to accelerate
the lipoprotein’s catabolism [29]. Animal research suggests
a further option of variation in APOE isoforms during
recycling of (TRL), a process stimulated by HDL. While
APOE3 is readily resupplied to plasma HDL particles
during TRL recycling, thus serving to maintain HDL levels
and further enhance hepatic clearance of remnants, APOE4
is believed to accumulate intracellularly. Therefore, APOE4
is not readily recycled and reattached to HDL particles,
thereby resulting in a decrease of HDL as well as decreasing
recycling of TRL [24]. Addressing these specific issues is
beyond the scope of this paper, yet our findings may suggest
a sex-specific component at that level. The Heeren study did
not address sex-specific variation. Determining HDL-C
subfractions in future research to address such questions as
whether the preferential binding of APOE isoforms and
variation in reclycling of these isoforms is present in
American Indian populations, or how carbohydrate affects
variation in specific HDL-C subfractions with and without
association to APOE genotypes, may identify underlying
explanations for our results. Furthermore, such information
may also indicate whether dietary lowering of HDL-C
actually reduces its cardioprotective properties.
Metabolically active adipose tissue may have contrib-
uted to our findings. Body fat was significantly higher in
both males and females with APOE4 allele, despite lower
caloric intake. Our adjustment for body fat cannot account
for variation in levels of adipokines [82] or the HDL
scavenger receptor class B type I (SR-BI) which is highly
expressed in adipose tissue [6]. Furthermore, sexual
dimorphism has been widely documented in both adipose
tissue levels and patterns, its hormones leptin and adipo-
nectin [81, 82], and energy homeostasis [79] all of which
are influenced by nutritional status and affect energy bal-
ance, carbohydrate and lipid metabolism and insulin
resistance [23, 47].
In this study we are limited by a cross-sectional
approach, the lack of specific information of HDL sub-
fractions and the subjective approach of recall as a measure
of dietary exposure. However, while cross-population
studies suggesting consistency among populations of
APOE effects on lipid variation in the face of inferred
dietary differences [21], this study incorporates a quantified
dietary variable and a sex-stratified approach in a larger
population. Whether the findings of this study reporting
sex-specific variation of HDL-C as an effect of carbohy-
drate-APOE polymorphism interaction are applicable to
other populations will depend on future research. Our
findings demonstrate the importance of understanding sex
differences in gene-by-nutrient interaction when examining
the complex architecture of HDL-C variation.
Summary
In conclusion, we identified sex-specific gene-by-nutrient
effects on HDL-C in American Indian participants of the
SHFS. Males, regardless of their APOE genotype, consis-
tently demonstrated an inverse relationship between
carbohydrate intake and plasma HDL-C levels. In con-
trast, genotype-by-carbohydrate-specific associations were
shown in females. Only those females with an e4 allele
demonstrated the inverse relationship between carbohy-
drate intake and HDL-C levels widely documented in many
populations, whereas those females without an e4 allele
showed no relationship of HDL-C to increased levels of
carbohydrate intake.
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54. North KE, Göring HH, Cole SA, Diego VP, Almasy L, Laston S,
Cantu T, Howard BV, Lee ET, Best LG, Fabsitz RR, MacCleur
JW (2006) Linkage analysis of LDL cholesterol in American
Indian populations: the Strong Heart Family Study. J Lipid Res
47:59–66
55. North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh JL,
Fabsitz RR, Roman MJ, MacCluer JW (2003) Genetic and
environmental contributions to cardiovascular disease risk in
American Indians: the strong heart family study. Am J Epidemiol
157(4):303–314
56. Ordovas JM (2004a) The quest for cardiovascular health in the
genomic era: nutrigenetics and plasma lipoproteins. Proc Nutr
Soc 63(1):145–152
57. Ordovas JM, Mooser V (2002) The APOE locus and the phar-
macogenetics of lipid response. Curr Opin Lipidol 13(2):113–
117
58. Ordovas JM, Corella D (2004b) Genes, diet and plasma lipids: the
evidence from observational studies, In: Ordovas A. P. S. a. J. M
(ed) Nutrigenetics and Nutrigenomics, Karger, Basel, pp 41–76
59. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein
MK (1999) Effects of a low-fat, high-carbohydrate diet on
VLDL-triglyceride assembly, production, and clearance. J Clin
Invest 104(8):1087–1096
60. Rader DJ (2006) Molecular regulation of HDL metabolism and
function: implications for novel therapies. J Clin Invest
116(12):3090–3100
61. Rashid S, Patterson BW, Lewis GF (2006) Thematic review
series: patient-oriented research. What have we learned about
HDL metabolism from kinetics studies in humans? J Lipid Res
47(8):1631–1642
62. Ravnskov U (2002) A hypothesis out-of-date: the diet-heart idea.
J Clin Epidemiol 55(11):1057–1063
63. Reilly M, Rader DJ (2006) Apolipoprotein E and coronary dis-
ease: a puzzling paradox. PLoS Med 3(6):e258
64. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF (1991)
The gender-specific apolipoprotein E genotype influence on the
distribution of lipids and apolipoproteins in the population of
Rochester, MN. I. Pleiotropic effects on means and variances.
Am J Hum Genet 49(6):1155–1166
65. Reilly SL, Kottke BA, Sing CF (1990) The effects of generation
and gender on the joint distributions of lipid and apolipoprotein
phenotypes in the population at large. J Clin Epidemiol
43(9):921–940
66. Ribalta J, Halkes CJ, Salazar J, Masana L, Cabezas MC (2005)
Additive effects of the PPARgamma, APOE, and FABP-2 genes
in increasing daylong triglycerides of normolipidemic women to
concentrations comparable to those in men. Clin Chem
51(5):864–871
67. Schakel SF, Sievert YA, Buzzard IM (1988) Sources of data for
developing and maintaining a nutrient database. J Am Diet Assoc
88(10):1268–1271
68. Schlierf G, Arab L, Oster P (1983) Influence of diet on high-
density lipoproteins. Am J Cardiol 52(4):17B–19B
69. Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza
J, Valencia ME (2006) Effects of traditional and western envi-
ronments on prevalence of type 2 diabetes in Pima Indians in
Mexico and the U.S. Diabetes Care 29(8):1866–1871
70. Sing C, Davignon J (1985) Role of the apolipoprotein E poly-
morphism in determining normal plasma lipid and lipoprotein
variation. Am J Hum Genet 37(2):268–285
71. Sobel E, Papp JC, Lange K (2002) Detection and integration of
genotyping errors in statistical genetics. Am J Hum Genet
70(2):496–508
72. Starc TJ, Shea S, Cohn LC, Mosca L, Gersony WM, Deckelbaum
RJ (1998) Greater dietary intake of simple carbohydrate is
associated with lower concentrations of high-density-lipoprotein
cholesterol in hypercholesterolemic children. Am J Clin Nutr
67(6):1147–1154
73. Stengard JH, Clark AG, Weiss KM, Kardia S, Nickerson DA,
Salomaa V, Ehnholm C, Boerwinkle E, Sing CF (2002) Contri-
butions of 18 additional DNA sequence variations in the gene
encoding apolipoprotein E to explaining variation in quantitative
measures of lipid metabolism. Am J Hum Genet 71(3):501–
517
96 Genes Nutr (2008) 3:87–97
123
74. Stevens J, Gautman SP, Keil JE (1993) Body mass index and fat
patterning as correlates of lipids and hypertension in an elderly,
biracial population. J Gerontol 48(6):M249–M254
75. Sun L, Wilder K, McPeek MS (2002) Enhanced pedigree error
detection. Hum Hered 54(2):99–110
76. Utermann G, Weisgraber KH, Weber W, Mahley RW (1984)
Genetic polymorphism of apolipoprotein E: a variant form of
apolipoprotein E2 distinguished by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis. J Lipid Res 25(4):378–382
77. Weinberg SL (2004) The diet-heart hypothesis: a critique. J Am
Coll Cardiol 43(5):731–733
78. Willett WC (2002) Dietary fat plays a major role in obesity: no.
Obes Rev 3:59–68
79. Woods SC, Gotoh K, Clegg DJ (2003) Gender differences in the
control of energy homeostasis. Exp Biol Med (Maywood)
228(10):1175–1180
80. Yang EJ, Chung HK, Kim WY, Kerver JM, Song WO (2003)
Carbohydrate intake is associated with diet quality and risk fac-
tors for cardiovascular disease in U.S. adults: NHANES III. J Am
Coll Nutr 22(1):71–79
81. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-
Zacas D, Mantzoros CS (2003) Body fat mass and macronutrient
intake in relation to circulating soluble leptin receptor, free leptin
index, adiponectin, and resistin concentrations in healthy humans.
J Clin Endocrinol Metab 88(4):1730–1736
82. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli
L, Guariento S, Bosello O, Zamboni M (2004) Adipocytokines,
fat distribution, and insulin resistance in elderly men and women.
J Gerontol A Biol Sci Med Sci 59(9):M935–M939
Genes Nutr (2008) 3:87–97 97
123
